NYXH - CONSENSUS CO - Nyxoah S.A.

This daily price chart for Nyxoah S.A. (NYXH) serves as an indicator for a business that combines the procurement of boards from contractors with final precision assembly, maintaining the premium value of Genio systems through reimbursement codes. The current figure is 5.38. Profitability growth is driven by scaling the production of microchips and electrodes, which significantly reduces costs as implant sales volumes increase.

This indicator represents the arithmetic mean of the asset's target values, calculated by experts based on discounted cash flows and market capitalization. The consensus forecast price action for Nyxoah S.A. (NYXH) reflects market confidence in the commercial success of its patented hypoglossal nerve stimulator, where rising targets confirm the high value of the company's technological advantage in apnea therapy.